Home › Funds › SR ONE CAPITAL MANAGEMENT, LP › ODTX
SR ONE CAPITAL MANAGEMENT, LP position in ODTX
ODYSSEY THERAPEUTICS INC · Health Care
SR ONE CAPITAL MANAGEMENT, LP reported holding 3,794,883 shares of ODTX (ODYSSEY THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$84.3M, representing 7.34% of its reported portfolio and ranking #6 among its reported holdings. SR ONE CAPITAL MANAGEMENT, LP has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How SR ONE CAPITAL MANAGEMENT, LP's ODTX position evolved
SR ONE CAPITAL MANAGEMENT, LP first disclosed a stake in ODTX in Q2 2026 at 3,794,883 shares (US$71.0M). The position peaked in Q3 2026 at 3,794,883 shares, worth US$84.3M. Across 2 filings, SR ONE CAPITAL MANAGEMENT, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,794,883 shares valued at US$84.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.79M | $71.00M | New |
| Q3 2026 | 3.79M | $84.32M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ODTX and 13F data
ODTX (ODYSSEY THERAPEUTICS INC) is a Health Care company. 75 other funds we track also report a position in ODTX — the largest reported positions include TPG GP A, LLC (US$82.0M), Lightspeed Management Company, L.L.C. (US$80.2M), ORBIMED ADVISORS LLC (US$66.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ODTX
- TPG GP A, LLC 3.69M sh · $82.00M · Q3 2026
- Lightspeed Management Company, L.L.C. 3.61M sh · $80.18M · Q3 2026
- ORBIMED ADVISORS LLC 3.00M sh · $66.69M · Q3 2026
- Sanofi 1.99M sh · $44.22M · Q3 2026
- MPM BioImpact LLC 1.29M sh · $28.64M · Q3 2026
- Affinity Asset Advisors, LLC 1.26M sh · $28.00M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.05M sh · $23.25M · Q3 2026
- Sands Capital Alternatives, LLC 875.00K sh · $19.44M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 831.66K sh · $18.48M · Q3 2026
- General Catalyst Group Management, LLC 810.27K sh · $18.00M · Q3 2026
- Foresite Capital Management V, LLC 729.60K sh · $16.21M · Q3 2026
- Vivo Capital, LLC 575.00K sh · $12.78M · Q3 2026
More on SR ONE CAPITAL MANAGEMENT, LP
FAQ
How long has SR ONE CAPITAL MANAGEMENT, LP held ODTX?
SR ONE CAPITAL MANAGEMENT, LP has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is SR ONE CAPITAL MANAGEMENT, LP's current position in ODTX?
As of Q3 2026, SR ONE CAPITAL MANAGEMENT, LP holds 3.79M shares of ODTX (ODYSSEY THERAPEUTICS INC), valued at $84.32M, representing 7.34% of its reported portfolio and ranking #6.
Has SR ONE CAPITAL MANAGEMENT, LP been buying or selling ODTX?
In the latest 13F filing (Q3 2026), SR ONE CAPITAL MANAGEMENT, LP held unchanged its position in ODTX. The position peaked in Q3 2026 at 3.79M shares.
Which other funds hold ODTX?
Other major institutional holders of ODTX include TPG GP A, LLC, Lightspeed Management Company, L.L.C., ORBIMED ADVISORS LLC, among 75 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.